Clinical trial
A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to…
NCT00195793 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00195793 |
|---|---|
| Title | A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin |
| Official title | A Multicenter, Randomized, Double-Blind, Prospective, Parallel Study to Compare the Safety and Efficacy of Fenofibrate or Ezetimibe as Add-On Therapy to Atorvastatin in Subjects With Combined Hyperlipidemia, Typical of the Metabolic Syndrome |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperlipidemia |
| Intervention type | Drug |
| Interventions | fenofibrate, ezetimibe, atorvastatin |
| Enrollment | 174 |
| Start date | Aug 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 4, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: